We are live on ! Find out more
GOSS icon

Gossamer Bio
GOSS

125 hedge funds and large institutions have $684M invested in Gossamer Bio in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 29 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 8

72% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 29

50% more call options, than puts

Call options by funds: $4.19M | Put options by funds: $2.79M

14% more funds holding

Funds holding: 110 → 125 (+15)

3.96% more ownership

Funds ownership: 69.28% → 73.24% (+4%)

0% more capital invested

Capital invested by funds: $684M → $684M (+$618K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
125
Holders Change
+15
Holders Change %
+13.64%
% of All Funds
2.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
50
Reduced
29
Closed
8
Calls
$4.19M
Puts
$2.79M
Net Calls
+$1.4M
Net Calls Change
+$285K

Top Buyers

Rank Fund Capital Flow
1
PAI
Palo Alto Investors
California
+$11.6M
2
MWNA
Marshall Wace North America
New York
+$11.1M
3
Goldman Sachs
Goldman Sachs
New York
+$8.46M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$5.09M
5
N
Nuveen
North Carolina
+$5.04M

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$6.82M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$4.26M
3
AG
Artal Group
Luxembourg
-$3.98M
4
Morgan Stanley
Morgan Stanley
New York
-$2.39M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$2.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
101
Bank of Montreal
Ontario, Canada
$38K -$17.7K -1,337 -31%
CG
102
Cutler Group
California
$31K +$33.1K +2,500 New
TRCT
103
Tower Research Capital (TRC)
New York
$28K -$74.1K -5,587 -71%
Macquarie Group
104
Macquarie Group
Australia
$26K – – –
Pacer Advisors
105
Pacer Advisors
Pennsylvania
$23K +$24.5K +1,848 New
Osaic Holdings
106
Osaic Holdings
Arizona
$17K +$6.63K +500 +54%
Royal Bank of Canada
107
Royal Bank of Canada
Ontario, Canada
$12K -$862 -65 -6%
CA
108
Clearstead Advisors
Ohio
$12K – – –
US Bancorp
109
US Bancorp
Minnesota
$11K -$1.06K -80 -8%
EWM
110
Endurance Wealth Management
Rhode Island
$9K – – –
QT
111
Quantbot Technologies
New York
$9K +$10.6K +800 New
PCM
112
Penserra Capital Management
California
$8K +$8.59K +648 New
ASN
113
Advisory Services Network
Georgia
$7K +$7.16K +540 New
Daiwa Securities Group
114
Daiwa Securities Group
Japan
$5K +$782 +59 +16%
Millennium Management
115
Millennium Management
New York
$4.8K +$2.5M +188,225 +95%
RE
116
RBC Europe
United Kingdom
$2.1K – – –
Group One Trading
117
Group One Trading
Illinois
$2K -$13.3K -1,000 -84%
MF
118
Manchester Financial
California
$2K – – –
PFWA
119
Paces Ferry Wealth Advisors
Georgia
$2K +$2.65K +200 New
TFA
120
Toth Financial Advisory
Virginia
$1K – – –
IRC
121
Investors Research Corp
Georgia
$1K +$915 +69 New
UBS Group
122
UBS Group
Switzerland
$1K +$1.54K +116 New
FCM
123
Farallon Capital Management
California
– -$1.3M -100,000 Closed
PCM
124
Pinz Capital Management
New York
– -$1.1M -84,300 Closed
Barclays
125
Barclays
United Kingdom
– -$685K -52,714 Closed
2 3 4
5
6

GOSS Hedge Fund Activity: Q3 2020 in Review

125 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q3 2020, worth a combined $684M — up 0.09% from $684M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new GOSS positions and 8 closed out — a net gain of 15 holders — while 50 added to existing stakes and 29 trimmed.

The largest buyer was Palo Alto Investors, adding an estimated $11.6M. The largest seller was Capital International Investors, cutting an estimated $6.82M.

  • 125 institutional investors held Gossamer Bio (GOSS) as of Q3 2020, up from 110 in Q2 2020.
  • Funds reported $684M of Gossamer Bio stock for Q3 2020, up 0.09% quarter-over-quarter.
  • 23 funds opened new Gossamer Bio positions in Q3 2020 and 8 closed out, a net change of +15 holders.
  • The largest Gossamer Bio buyer in Q3 2020 was Palo Alto Investors, an estimated $11.6M added.
  • The largest Gossamer Bio seller in Q3 2020 was Capital International Investors, an estimated $6.82M sold.

Based on aggregated 13F filings for Q3 2020.